| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.37 | 0.2 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.36 | 0.2 |
| mRNA | Crizotinib | FIMM | pan-cancer | AAC | -0.21 | 0.3 |
| mRNA | marinopyrrole A | CTRPv2 | pan-cancer | AAC | -0.2 | 3e-05 |
| mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | -0.19 | 4e-06 |
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | -0.19 | 0.02 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | -0.19 | 0.002 |
| mRNA | GDC-0449 | FIMM | pan-cancer | AAC | -0.18 | 0.4 |
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | -0.18 | 3e-05 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.18 | 0.0005 |